Weekly docetaxel versus docetaxel/gemcitabine in elderly/poor performance status (PS) patients (pts) with stage IIIB/IV non-small cell lung cancer (NSCLC): Randomized phase III trial of the Minnie Pearl Cancer Research Network

被引：0
|
作者：
Greco, F. A.
Spigel, D. R.
Burris, H. A., III
Shipley, D. L.
Farley, C.
Gandhi, J.
Houston, G. A.
Hainsworth, J. D.
机构：
[1] Tennessee Oncol, Sarah Cannon Res Inst, Nashville, TN USA
[2] Associates Oncol & Hematol, Chattanooga, TN USA
[3] Jackson Oncol Associates, Jackson, MS USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7534
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Weekly docetaxel versus Docetaxel/Gemcitabine in the treatment of elderly or poor performance status patients with advanced nonsmall cell lung cancer - A Randomized phase 3 trial of the minnie pearl cancer research network
    Hainsworth, John D.
    Spigel, David R.
    Farley, Cindy
    Shipley, Dianna L.
    Bearden, James D.
    Gandhi, Jitendra
    Houston, Gerry Ann
    Greco, F. Anthony
    CANCER, 2007, 110 (09) : 2027 - 2034
  • [2] Weekly docetaxel versus weekly docetaxel/gemcitabine as first-line therapy for patients who are elderly or with poor performance status (PS) or with serious comorbidities with advanced non-small cell lung cancer (NSCLC) : Interim safety analysis of a Minnie Pearl Cancer Research Network phase III
    Mainwaring, MG
    Hainsworth, JD
    Spigel, DR
    Gray, JR
    Shipley, DL
    Morrissey, LH
    Greenwell, S
    Joseph, G
    Bradof, JE
    Schnell, FM
    Greco, FA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 658S - 658S
  • [3] A phase II randomized trial of docetaxel weekly or every 3 weeks in elderly and/or poor performance status (PS) patients (pts) with advanced non-small cell lung cancer (NSCLC).
    Lilenbaum, R
    Rubin, M
    Samuel, J
    Boros, L
    Chidiac, T
    Seigel, L
    Graham, P
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 630S - 630S
  • [4] A multicenter phase II study of docetaxel (D) or docetaxel/gemcitabine (G) weekly in advanced non-small cell lung cancer (NSCLC) in elderly and/or poor performance status (PS) patients (pts) - (GFPC 0202).
    Le Caer, H
    Gimenez, C
    Fournel, P
    Chouaid, C
    Robinet, G
    Jullian, H
    Vergnenegre, A
    Bayle, S
    Barlesi, F
    Barriere, JR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 657S - 657S
  • [5] Preoperative docetaxel and gemcitabine in resectable non-small cell lung cancer: A phase II trial of the Minnie Pearl Cancer Research Network
    Thompson, D. S.
    Spigel, D. R.
    Greco, F. A.
    Yardley, D. A.
    Burris, H. A., III
    Vazquez, E.
    Erland, J.
    Shipley, D. L.
    Spremulli, E.
    Hainsworth, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] A phase I/II trial of weekly docetaxel and gefitinib in elderly patients (≥ 70) with stage IIIB/IV non-small cell lung cancer (NSCLC).
    Stinchcombe, TE
    Socinski, MA
    Choksi, J
    Bakri, K
    Taylor, M
    Tynan, MT
    Mears, A
    Smith, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 685S - 685S
  • [7] A phase I/II trial of weekly docetaxel and gefitinib in elderly patients (≥70) with stage IIIB/IV non-small cell lung cancer (NSCLC)
    Stinchcombe, T
    Socinski, M
    Choksi, J
    Bakri, K
    Taylor, M
    Tynan, M
    Mears, A
    Smith, C
    LUNG CANCER, 2005, 49 : S270 - S270
  • [8] A phase I/II trial of weekly docetaxel and gefitinib in elderly patients with stage IIIB/IV non-small cell lung cancer
    Stinchcombe, Thomas E.
    Buzkova, Petra
    Choksi, Janak
    Taylor, Mark
    Bakri, Kamal
    Gillenwater, Heidi
    Tynan, Maureen
    Mears, Andrea
    Jones, Paul E.
    Socinski, Mark A.
    LUNG CANCER, 2006, 52 (03) : 305 - 311
  • [9] A randomized phase iib trial of gemcitabine and cisplatin (GC) versus gemcitabine and docetaxel (GD) in stage IIIB/IV advanced non-small cell lung cancer (NSCLC) -: An Galician lung cancer group study
    Rubio, J. Casal
    Estevez, S. Vazquez
    Rivera, F. Vazquez
    Salfago, Mercedes
    Llorca, Cristina
    Ramos, Manuel
    Perez, Eva
    Cervera, Jose M.
    Garcia, Jesus
    Gomez, Jesus Garcia
    Mata, Jesus Garcia
    ANNALS OF ONCOLOGY, 2006, 17 : 224 - 224
  • [10] Weekly docetaxel as a single agent and in combination with gemcitabine in elderly and poor performance status patients with advanced non-small cell lung cancer
    Hainsworth, JD
    Burris, HA
    Greco, FA
    SEMINARS IN ONCOLOGY, 2001, 28 (03) : 21 - 25
12345